| mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-07 |
| mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
6e-07 |
| mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
0.21 |
7e-07 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
1e-06 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
| mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
| mRNA |
FTI-277 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
3e-05 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
4e-05 |
| mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
0.22 |
5e-05 |
| mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
5e-05 |